Torque'S Glimtor Pm1 Tablets

Torque’s Glimtor PM1 Tablets contain Glimepiride, a sulphonylurea antihyperglycaemic agent acts mainly by stimulating insulin release from pancreatic beta cells, Pioglitazone, a thiazolidinedione antihyperglycaemic agent acts by a reduction of insulin resistance and Metformin, a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.

Dosage Form

Tablet

Route of Administration

Oral

Composition

Each uncoated bilayered tablet contains:

Glimepiride I.P. 1 mg
Pioglitazone Hydrochloride Eq. to Pioglitazone I.P. 15 mg
Metformin Hydrochloride (as extended release form) I.P. 500 mg
Excipients q.s.

Indications

Indicated for the treatment of type II diabetes mellitus when diet, exercise, and treatment with a single antidiabetic agent do not provide adequate glycemic control.

Storage

Store protected from light & moisture at a temperature not exceeding 30°C.

Precautions

Avoid use in patients with severe renal impairment, metabolic acidosis, diabetic ketoacidosis, severe heart failure, hepatic insufficiency, acute alcohol intoxication, or conditions causing tissue hypoxia. Monitor for hypoglycaemia and signs of lactic acidosis. Use caution with alcohol, iodinated contrast agents, and medicines that may affect blood glucose or renal function.

Presentation

10 x 15 Tablets

GLOBAL HORIZONS

Your Efforts Extended Through a Partnership That's Better Together

Become a Dealer